Letter to Editor


Levofloxacin-induced black hairy tongue (BHT) in a 30-year-old female COVID-19 infected patient

Maria Tzikopoulou1
,  
Evangelos Potolidis2
,  
Charalampos Mandros3
,  
Eleni-Isidora Perdikouri4

1 Second Internal Medicine Department – Covid, General Hospital of Volos, Volos, Greece

2 Second Internal Medicine Department – Covid, General Hospital of Volos, Volos, Greece

3 Second Internal Medicine Department – Covid, General Hospital of Volos, Volos, Greece

4 Oncology Department, General Hospital of Volos, Volos, Greece

Address correspondence to:

Evangelos Potolidis

MD, ThB, MA, Consultant in Internal Medicine and Diabetology, General Hospital of Volos, Volos,

Greece

Access full text article on other devices

Access PDF of article on other devices

Article ID: 101264Z01TM2021

doi: 10.5348/101264Z01TM2021CR

How to cite this article

Tzikopoulou M, Potolidis E, Mandros C, Perdikouri E-I. Levofloxacin-induced black hairy tongue (BHT) in a 30-year-old female COVID-19 infected patient. Int J Case Rep Images 2021;12:101264Z01TM2021.

ABSTRACT

No Abstract 

Keywords: Black hairy tongue (BHT), COVID-19, Levofloxacin

To the Editors


Black hairy tongue (BHT) is a condition in which the filiform papillae on the dorsal surface of the tongue are elongated and hypertrophied [1],[2],[3]. The tongue is hairy and discolored, the color is usually black, but brown, green, or yellow appearances have been reported. Patients with this condition are either asymptomatic or they rarely mention a burning sensation of the tongue or halitosis. Similar conditions that mimicking BHT should be ruled out are acanthosis nigricans, hairy leukoplakia, and melanocytic nevi. Xerostomia, smoking, coffee, poor oral hygiene and use of medication are risk factors for acquiring BHT [4]. Black hairy tongue is also associated with various conditions that cause immune compromise, such as malignancies, human immunodeficiency virus (HIV), graft versus host disease (GVHD) and recent radiation therapy to the head and neck region [3],[4]. A lot of medications [5] have been reported to induce hairy discoloration of the tongue like antibiotics, proton pump inhibitors, antipsychotics, chemotherapeutics drugs, methyldopa, and interferon. Macrolides, linezolid [6], tetracyclines, penicillins, cephalosporins, and metronidazole are among the anti-infective agents that are mainly involved in this condition. The association between microbial infections and development of BHT has been debated for many years and it seems that bacterial proliferation is secondary to antibiotic use, as well as the elongation of the filiform papillae. The alteration of the oral microflora gives rise to resistant bacteria and fungi [7], which are trapped and proliferate in the filiform papillae. Fungi such as Candida and Aspergillus are thought to aggravate the condition [8].

We report a 30-year-old female who presented with a history of fever, cough, and myalgias. After ordering blood tests, a chest X-ray and taking a nasopharyngeal swab specimen for a SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) test, the patient received levofloxacin. The test was positive; the patient self-isolated at home and was treated as an outpatient with levofloxacin, paracetamol, and oral fluids. The symptoms resolved without major complications like dyspnea or hypoxemia. Oxygen saturation was self-monitored daily and she was in continuous communication with her treating physician. She was prescribed levofloxacin for seven days. On the fifth day she complained about a burning sensation on the dorsal surface of the tongue and noticed black discoloration of her tongue. The physician examined the patient using personal protective equipment and collected a sample from the affected area, which was sent for culture as a specimen from the tongue (Figure 1). The specimen was negative for bacteria and yeast. Levofloxacin was stopped after seven days and patient’s condition gradually improved. Tongue appearance on day 13 was normal without discoloration and burning sensation resolved.

Black hairy tongue is a self-limiting, usually asymptomatic condition which resolves after withdrawing the considered causative agent and performing oral hygiene. Discoloration of the tongue is accompanied by elongated filiform papillae (12–18 mm) along with hypertrophy (2 mm width). Antibiotics can change the mouth flora and chromogenic bacteria contribute to tongue discoloration. Moreover, the use of antimicrobial agents can lead to inadequate desquamation and hairy elongation—hypertrophy of the filiform papillae. Amatus Lusitanus first described this disease in 1557. Multiple factors can contribute to this condition, but the pathophysiology is not yet fully understood. Clinical examination alone is sufficient for the diagnosis of BHT, while biopsy of the affected tissue is not required.

We report in this letter the first COVID-19 positive patient who developed levofloxacin-induced BHT. After conducting a literature search using Pubmed, we noticed only one case report [9] in which a patient acquired BHT during treatment with Piperacillin/Tazobactam and levofloxacin due to multidrug resistant (MDR) Pseudomonas aeruginosa. The main oral manifestation of COVID-19 is gustatory impairment, however, various oral mucosal lesions such as, ulcers, erosions, plaques, macules, and geographical tongue, varying in size, color, and appearance have been described [10]. Clinicians should be aware about this benign condition which requires only visual inspection and often follows antibiotic administration, of equal importance is patient education about this condition, as it is an unusual one, and it may be erroneously attributed to a malignancy. This tongue disease is self-limiting, does not require antifungal therapy, and is resolved after discontinuation of the causative agent, while improving oral hygiene.

Figure 1: Black haired tongue during treatment with levofloxacin 500 mg once daily.

REFERENCE


1.

Ramsakal A, Mangat L. Images in clinical medicine. Lingua villosa nigra. N Engl J Med 2007;357(23):2388. [CrossRef] [Pubmed] Back to citation no. 1  

2.

Sheikh Z, Khan AS, Khan S. Lingua villosa nigra. Lancet 2011;377(9772):1183. [CrossRef] [Pubmed] Back to citation no. 1  

3.

Gurvits GE, Tan A. Black hairy tongue syndrome. World J Gastroenterol 2014;20(31):10845–50. [CrossRef] [Pubmed] Back to citation no. 1  

4.

Schlager E, St Claire C, Ashack K, Khachemoune A. Black hairy tongue: Predisposing factors, diagnosis, and treatment. Am J Clin Dermatol 2017;18(4):563–9. [CrossRef] [Pubmed] Back to citation no. 1  

5.

Thompson DF, Kessler TL. Drug-induced black hairy tongue. Pharmacotherapy 2010;30(6):585–93. [CrossRef] [Pubmed] Back to citation no. 1  

6.

Khasawneh FA, Moti DF, Zorek JA. Linezolid-induced black hairy tongue: A case report. J Med Case Rep 2013;7:46. [CrossRef] [Pubmed] Back to citation no. 1  

7.

Lineback M. The biocenologic approach to black hairy tongue with new concepts of its treatment: Secondary mycosis linguae of pathologic significance. The Laryngoscope 1959;69(9):1194–212. [CrossRef] Back to citation no. 1  

8.

Mangold AR, Torgerson RR, Rogers RS 3rd. Diseases of the tongue. Clin Dermatol 2016;34(4):458–69. [CrossRef] [Pubmed] Back to citation no. 1  

9.

Ren J, Zheng Y, Du H, et al. Antibiotic-induced black hairy tongue: Two case reports and a review of the literature. J Int Med Res 2020;48(10):1–11. [CrossRef] [Pubmed] Back to citation no. 1  

10.

Farid H, Khan M, Jamal S, Ghafoor R. Oral manifestations of Covid-19 – A literature review. Rev Med Virol 2021;e2248. [CrossRef] [Pubmed] Back to citation no. 1  

SUPPORTING INFORMATION


Author Contributions

Maria Tzikopoulou - Conception of the work, Design of the work, Drafting the work, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Evangelos Potolidis - Conception of the work, Design of the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Charalampos Mandros - Conception of the work, Design of the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Eleni-Isidora Perdikouri - Conception of the work, Design of the work, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Data Availability Statement

The corresponding author is the guarantor of submission.

Consent For Publication

Written informed consent was obtained from the patient for publication of this article.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Competing Interests

Authors declare no conflict of interest.

Copyright

© 2021 Maria Tzikopoulou et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.